ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

MYNZ Mainz BioMed NV

0.68
-0.046 (-6.34%)
06 Jun 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2023Jun 2023Sep 2023Dec 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 250k249k181k215k
Operating Income -6.56M-7.93M-5.64M-6.59M
Pre Tax Income -6.56M-8.25M-6.3M-5.18M
Net Income -6.56M-8.25M-6.3M-5.18M
Preferred Dividends 0000
Basic Earnings Per Share (EPS) 0000
EBIT -6.56M-8.33M-6.3M-5.04M
EBITDA -6.38M-7.65M-5.36M-6.46M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 281k493k577k529k895k
Operating Income -921k-674k-9.73M-26.18M-26.65M
Pre Tax Income -957k-587k-11.69M-26.39M-26.3M
Net Income -957k-587k-11.69M-26.39M-26.3M
Preferred Dividends 00000
Basic Earnings Per Share (EPS) -0.171-0.105-0.973-1.804-1.242
EBIT -921k-674k-9.73M-26.18M-26.15M
EBITDA -867k-614k-9.66M-25.92M-25.78M